Does Mounjaro Affect the Depo Injection?

The real decision: does the depo injection sit in the same risk category as the pill?

There is a common misconception that Mounjaro interacts with all hormonal contraception in the same way. It doesn't. The interaction concern specifically centres on oral contraceptives, tablets swallowed and absorbed through the digestive tract. Because tirzepatide slows gastric emptying, the window during which the pill reaches peak absorption is altered, which is why NHS England's guidance on weight-management injections advises women on the pill to use a non-oral backup method (such as condoms) for the first four weeks of Mounjaro and for four weeks after any dose increase.

The depo-provera injection works differently. Medroxyprogesterone acetate is delivered directly into muscle tissue, releasing steadily into the bloodstream without touching the gastrointestinal system at all. That gut-absorption step (the one Mounjaro can disrupt) simply isn't part of how the depo works. So the pill-specific guidance does not extend to the depo injection under current NHS advice.

That distinction matters practically. If you are already on the depo and thinking about Mounjaro for weight management, you are not being asked to add a backup method or change your contraceptive approach solely because of this interaction.

What your prescriber still needs to know before you start

None of the above removes the need for an honest conversation with your prescriber. Contraceptive history is part of a thorough clinical assessment, and there are a few considerations that go beyond the absorption question.

First, weight loss itself can influence hormone levels and, over time, fertility. Some people who have experienced irregular periods related to higher body weight find that their cycle changes as they lose weight on treatment. This doesn't affect the depo's contraceptive reliability directly, but it is worth being aware of if you are monitoring your cycle for any reason.

Second, if you are approaching the end of a depo cycle and intending to switch contraceptive methods, the timing of starting Mounjaro is worth discussing. Starting a new medicine and changing contraception at the same time can make it harder to attribute any side effects to their cause.

Third, Mounjaro is not recommended during pregnancy, while breastfeeding, or for those trying to conceive. The MHRA advises using effective contraception while on GLP-1 medicines and for a wash-out period before attempting conception. If any of those circumstances apply to you, or may apply in the near future, that should be at the centre of your consultation, not a footnote. You can find more detail on how tirzepatide works and what it interacts with on our page on how the Mounjaro injection works.

Injection site considerations: keeping both injections separate

There is one practical point that sometimes gets overlooked. If you are having a depo injection and also administering Mounjaro yourself, you should not use the same injection site for both on the same occasion. Mounjaro is injected subcutaneously, into the fatty layer just beneath the skin of the abdomen, thigh, or upper arm. The depo injection goes into muscle, typically the upper arm or buttock, and is administered by a healthcare professional.

The two routes are different enough that there is no clinical conflict, but rotating your Mounjaro sites carefully still matters for your comfort and to avoid local tissue reactions. Our guide to changing Mounjaro injection sites covers the rotation principles in detail. If you ever notice unexpected swelling or discomfort at a Mounjaro injection site, our page on injection-site swelling explains what is normal and what warrants a call to your prescriber.

On the practical side: used Mounjaro pens are sharps waste and should be disposed of in an approved container, a sharps bin is the safe option if you don't already have one at home.

Putting it all together before you decide

For most people on the depo injection, starting Mounjaro does not require a change to their contraceptive arrangement. The specific absorption concern that makes the pill more complicated to manage alongside tirzepatide does not apply to a depot intramuscular injection in the same way. That is reassuring, and it is a question worth asking clearly rather than assuming the worst.

What still matters is telling your prescriber everything: your current contraceptive method, where you are in your depo cycle, your plans around pregnancy, and any other medicines you take. A prescriber reading your full picture can give guidance that applies to you specifically, not just the general population. If you are weighing up the cost and practicalities of starting treatment, our Mounjaro pricing page sets out what private treatment involves financially. And if you have further questions about the depo interaction specifically, our dedicated page on Mounjaro and the depo injection goes into additional depth on real-world scenarios our prescribers encounter.

The NHS England guidance referenced above is the current UK standard; this area of clinical guidance continues to be refined as more people use these medicines, so your prescriber's up-to-date knowledge is more valuable here than any static page. When you are ready to move forward, start your free consultation and one of our GPhC-registered prescribers will go through this with you directly.